Independence Bank of Kentucky Trims Holdings in Kenvue Inc. (NYSE:KVUE)

Independence Bank of Kentucky decreased its holdings in Kenvue Inc. (NYSE:KVUEFree Report) by 70.6% during the fourth quarter, HoldingsChannel.com reports. The firm owned 1,786 shares of the company’s stock after selling 4,289 shares during the quarter. Independence Bank of Kentucky’s holdings in Kenvue were worth $38,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Clearstead Advisors LLC purchased a new position in shares of Kenvue during the third quarter valued at $25,000. Planned Solutions Inc. purchased a new position in shares of Kenvue during the fourth quarter valued at $27,000. AdvisorNet Financial Inc purchased a new position in shares of Kenvue during the third quarter valued at $28,000. Global Retirement Partners LLC purchased a new position in shares of Kenvue during the third quarter valued at $28,000. Finally, Venturi Wealth Management LLC purchased a new position in shares of Kenvue during the third quarter valued at $28,000. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Kenvue Stock Performance

Shares of NYSE KVUE opened at $20.33 on Thursday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.12 and a quick ratio of 0.78. The business has a 50-day simple moving average of $20.04 and a two-hundred day simple moving average of $20.23. Kenvue Inc. has a fifty-two week low of $17.82 and a fifty-two week high of $27.80.

Kenvue (NYSE:KVUEGet Free Report) last issued its quarterly earnings results on Thursday, February 8th. The company reported $0.31 earnings per share for the quarter, topping the consensus estimate of $0.28 by $0.03. The business had revenue of $3.67 billion during the quarter, compared to the consensus estimate of $3.78 billion. Kenvue had a return on equity of 15.62% and a net margin of 9.87%. The business’s quarterly revenue was down 2.7% on a year-over-year basis. On average, equities analysts forecast that Kenvue Inc. will post 1.17 EPS for the current year.

Kenvue Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, February 28th. Shareholders of record on Wednesday, February 14th were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 3.94%. The ex-dividend date was Tuesday, February 13th.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Royal Bank of Canada cut their price target on Kenvue from $25.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 9th. The Goldman Sachs Group assumed coverage on Kenvue in a research note on Friday, March 1st. They set a “neutral” rating and a $20.00 price target on the stock. JPMorgan Chase & Co. dropped their price objective on Kenvue from $25.00 to $24.00 and set an “overweight” rating on the stock in a research report on Friday, February 9th. UBS Group raised their price objective on Kenvue from $20.00 to $23.00 and gave the company a “neutral” rating in a research report on Tuesday, December 19th. Finally, William Blair assumed coverage on Kenvue in a research report on Wednesday. They set a “market perform” rating on the stock. Eight investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, Kenvue currently has an average rating of “Hold” and an average target price of $25.42.

View Our Latest Stock Report on Kenvue

Kenvue Profile

(Free Report)

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

Read More

Want to see what other hedge funds are holding KVUE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kenvue Inc. (NYSE:KVUEFree Report).

Institutional Ownership by Quarter for Kenvue (NYSE:KVUE)

Receive News & Ratings for Kenvue Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kenvue and related companies with MarketBeat.com's FREE daily email newsletter.